CooperVision International Limited (CVIL)
19
3
3
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
42%
5 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Optimization for Toric Contact Lenses
Role: lead
Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye
Role: lead
Comprehensive Assessment of Multiple Products (CAMP)
Role: lead
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
Role: lead
Performance of Two Daily Disposable Multifocal Contact Lenses
Role: lead
Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses
Role: lead
Short-term Study of Two Soft Contact Lenses in Wearers With Low Astigmatism
Role: lead
A Clinical Comparison of Two Soft Toric Contact Lenses
Role: lead
Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)
Role: collaborator
Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia
Role: lead
North American Comfilcon A Clinical Study
Role: lead
Refitting Multifocal Contact Lens Wearers With a Different Multifocal Contact Lens
Role: lead
Clinical Evaluation of Reusable Soft Contact Lenses
Role: lead
Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
Role: lead
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
Role: lead
Management of Myopia in University Students Using Dual Focus Soft Contact Lenses
Role: collaborator
Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software
Role: lead
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
Role: lead
High Refractive Index Material 510(k)
Role: lead
All 19 trials loaded